Trial to Examine the Effect of Natural Anti- Obesity Agent (Phaseolus Vulgaris) Among Women of Lahore

A Randomized Double Blind Study to Examine the Effect of Natural Anti-obesity Agent Among Women of Lahore

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05451927

Acronym

PVE-AO

Enrollment

Registered

2022-07-11

Start date

2022-10-27

Completion date

2023-12-30

Last updated

2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

Weight loss

Brief summary

This double-blind randomized placebo-controlled trial will test the hypothesis that administration of Phaseolus Vulgaris supplementation to women in Lahore, Pakistan, who are overweight will induce the weight loss (Primary outcome) and changes in body composition (Waist circumference) secondary outcome.

Interventions

DIETARY_SUPPLEMENTPhaseolus Vulgaris

Weight loss

DIETARY_SUPPLEMENTPlacebo

Placebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* BMI ranges from 25-40 * Consistently stable body weight for at least 6 months * Good general health * No ongoing drug treatment for weight reduction * Commitment to avoid any changes in lifestyle throughout the test period * Age between 18-45 years * Women resident of Lahore

Exclusion criteria

* Pregnant or breast-feeding females * People with Type 2 diabetes * People with any other chronic diseases * Weight reduction treatment during the 6 months prior to the study

Design outcomes

Primary

Measure	Time frame	Description
Body weight	3 months	change in body weight

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026